Latika Puri, MD
Latika Puri, MD

Latika Puri, MD

Assistant Member, St. Jude Faculty

  • Assistant Director, Hematology/Oncology Fellowship Program




Undergraduate - Carmel Convent School, Chandigarh, India
Undergraduate - Govt. Senior Secondary School, Sector 16, Chandigarh, India
MBBS - Government Medical College, Amritsar, India
Internship and Residency (Pediatrics) - John H Stroger Hospital of Cook County, Chicago, Illinois
Fellowship (Pediatric Hematology/Oncology) - UCSF Benioff Children’s Hospital and Research Center, Oakland, California

Board Certification

  • General Pediatrics, American Board of Pediatrics
  • Pediatric Hematology/ Oncology, American Board of Pediatrics


  • Tennessee Medical Board, 53619 (12/2015, active)
  • California Medical License, A120200 (2/2012, active)

Selected Publications

Zhao P, Aguilar AE, Lee JY, Paul LA, Suh JH, Puri L, Zhang M, Beckstead J, Witkowski A, Ryan RO, Saba JD. Sphingadienes show therapeutic efficacy in neuroblastoma in vitro an in vivo by targeting the AKT signaling pathway. Invest New Drugs Jan 16, 2018.

Puri L, Nottage KA, Hankins JS, Anghelescu DL. State of the Art Management of Acute Vaso –  occlusive Pain in Sickle Cell Disease. Pediatric Drugs Feb;20(1):29-42, 2018.

Puri L, Saba J. Getting a Clue from 1q: Gain of Chromosome 1q in Cancer. J Cancer Biol Res  2(3):1053, 2014.

Last update: May 2018